Laurent Pradier
12Patents
3h-index
43Co-inventors
56Inventor score
Filing activity: Oct 8, 1999 → Jun 2, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8614299B2 | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | Chemistry; Metallurgy | 25 | Active |
| US6653088B1 | Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the &bgr;-amyloid peptide | Physics | 7 | Expired |
| US8343493B2 | Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs | Chemistry; Metallurgy | 3 | Active |
| US7070940B2 | Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein | Human Necessities | 3 | Expired |
| US7700823B2 | Transgenic animals exhibiting major disorders related to Alzheimer's disease | Human Necessities | 2 | Expired |
| US9364519B2 | Pharmaceutical composition for use in the treatment of a neurodegenerative disease | Human Necessities | 1 | Active |
| US8492610B1 | Transgeneic animal expressing a multiple mutated form of presenilin 1 | Human Necessities | 0 | Expired |
| US10112991B2 | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | Chemistry; Metallurgy | 0 | Active |
| US9382312B2 | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | Chemistry; Metallurgy | 0 | Active |
| US8273548B2 | Nucleic acids encoding a human PAP1 polypeptide | Chemistry; Metallurgy | 0 | Active |
| US7803538B2 | Method for detecting Alzheimer's disease | Chemistry; Metallurgy | 0 | Expired |
| US7132396B2 | Compositions which can be used for regulating the activity of parkin | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.